+ 49 (0) 2204 2918806

Botswana Pharmaceuticals and Healthcare Report Q4 2013

SKU:2049-2421 / 328367
Publication Date:31.07.2013
Language version:English
Report Type:Report
Lieferzeit:2-3 Tage
Nr of pages:53 pages
Rating:Für diese Studie liegt keine Bewertung vor.
$1,295.00   *
* Click here to switch the currency you want to pay in.
More about this report
Table of Contents
Other relevant reports
Our guarantee

Content of the report

BMI View: Botswana remains as one of the more advanced countries in the African region in terms of its
provision of healthcare. However, the region as a whole remains impoverished and it is unlikely that we will
see significant foreign investments. Consequently, we maintain our view that the country must see
significant improvements to its living standards before it can attract pharmaceutical and healthcare firms.
Headline Expenditure Projections:
Pharmaceuticals: BWP1.50bn (US$198mn) in 2012 to BWP1.65bn (US$198mn) in 2013; +9.7% in local
currency terms and +0.1% in US dollar terms. Forecast in line with Q312.
Healthcare: BWP6.72bn (US$883mn) in 2012 to BWP7.48bn (US$896mn) in 2013; +11.2% in local
currency terms and +1.4% in US dollar terms, due to currency fluctuations. Forecast unchanged from